ING/WellPoint and Aetna may or may not be talking, but several Aetna shareholders definitely want them to. Following Aetna’s rejection of their bid, which analysts valued at close to $70 a share, Aetna announced that it intended to split into two companies. Its shares have since fallen to the low $50s, which is at least better that its eight-year low of $38.50 a share reached in February. The complaining shareholders thought the takeover rejection was an error and have filed suit against Aetna in a Connecticut Superior Court alleging that it refused to adequately consider the ING/WellPoint bid simply to protect current management.
Topics Lawsuits
Was this article valuable?
Here are more articles you may enjoy.
Viewpoint: How Federal Ban on Intoxicating Hemp Products Will Reshape Risk, Coverage 
NC Roofers Caught in Farm Bureau’s Sting Sentenced to Probation, Restitution 
Lockton Named in NBA Investigation Into Clippers Salary Cap Circumvention 
25 Years Later: IJ’s Past and Continued Coverage of the Insurance Impact of 9/11 From This Issue
